Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Edwards Lifesciences

Dow Jones Futures: What To Do After Stock Market Sell-Off; White House Warns Of 'Extraordinarily Elevated' Inflation

Dow Jones futures were higher early. Here's what to do after Monday's stock market sell-off ahead of today's key inflation report.

Investors Business Daily

Heart Valve Maker Eyes Breakout After Getting An FDA Approval

Heart Valve Maker Eyes Breakout After Getting An FDA Approval

As heart valve maker Edwards Lifesciences wins a new FDA approval, the stock looks to pump out a fresh breakout.

Investors Business Daily

Raytheon, Shell Lead Five Stocks Setting Up, Breaking Out From Strong Sectors

Raytheon, Shell Lead Five Stocks Setting Up, Breaking Out From Strong Sectors

Raytheon Technologies and Shell are just below buy points, headlining five stocks from strong sectors.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

FDA Approves Edwards Lifesciences' Resilia Valve For Mitral Replacement Surgery

The FDA has approved Edwards Lifesciences Corp's (NYSE: EW) Mitris Resilia valve, a tissue valve replacement specifically designed for the heart's mitral position.

What 9 Analyst Ratings Have To Say About Edwards Lifesciences

Analysts have provided the following ratings for Edwards Lifesciences (NYSE:EW) within the last quarter:

Analyst Ratings For Edwards Lifesciences

Analysts have provided the following ratings for Edwards Lifesciences (NYSE:EW) within the last quarter:

This Foreboding Sign Looms Over Edwards Lifesciences's Chart

If history is any guide, there may be trouble ahead for shares of Edwards Lifesciences (NYSE:EW). A so-called "death cross" has formed on its chart and, not surprisingly, this could be bearish for the stock.

inkl

Read news from The Economist, FT, and more,
with one subscription

Where Edwards Lifesciences Stands With Analysts

Where Edwards Lifesciences Stands With Analysts

Analysts have provided the following ratings for Edwards Lifesciences (NYSE:EW) within the last quarter:

Edwards Lifesciences Q4 Earnings Fall Short Of Expectations, Reaffirms FY22 Outlook

Edwards Lifesciences Q4 Earnings Fall Short Of Expectations, Reaffirms FY22 Outlook

Heart device company Edwards Lifesciences Corp (NYSE: EW) posted

Edwards Lifesciences: Q4 Earnings Insights

Edwards Lifesciences: Q4 Earnings Insights

Edwards Lifesciences (NYSE:EW) reported its Q4 earnings results on Wednesday, January 26, 2022 at 04:15 PM. Here's what investors need to know about the announcement.

Omicron Weighs On Edwards Lifesciences In The Fourth Quarter — So, What's Next?

Omicron Weighs On Edwards Lifesciences In The Fourth Quarter — So, What's Next?

The omicron variant weighed on Edwards in late 2021, leading to a fourth-quarter miss and pushing EW stock into a dive Thursday.

Investors Business Daily

Preview: Edwards Lifesciences's Earnings

Preview: Edwards Lifesciences's Earnings

Edwards Lifesciences (NYSE:EW) is set to give its latest quarterly earnings report on Wednesday, 2022-01-26. Here's what investors need to know before the announcement. Analysts estimate that Edwards Lifesciences will likely report an Earnings Per Share (EPS) of $0.55.

Organisations

American Express

IBD MarketSmith

IBD Leaderboard

Edwards Lifesciences

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Topics

inkl

Read news from The Economist, FT, and more,
with one subscription

Places

265,226 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play